Dr. Antonio Delgado (Barcelona, 1958) obtained the PhD in Pharmacy in 1986 by the University of Barcelona (UB), where he is Associated Professor of Organic Chemistry since 1988 and Full Professor (after National Accreditation) since 2010.
After a doctoral thesis in the field of Medicinal Chemistry, he spent two years as postdoctoral fellow in Jon Clardy’s lab (Cornell University) working in the total synthesis of natural products. Back in Spain, he participated in several collaborative projects with CSIC, all of them addressed at the design and synthesis of pheromone analogues and to the development of synthetic methodology based on organometallic processes.
Some years later, he became one of the co-founders of the Research Unit on BioActive Molecules (RUBAM) and the Head of the UB-CSIC Associated Unit of Medicinal Chemistry
His present research interests are the design, the synthesis, and the cellular evaluation of modulators of the sphingolipid metabolism with potential therapeutic applications, in particular to rare diseases. He is also interested in the development of pharmacological tools and chemical probes for the study of the biophysical properties of sphingolipids and the enzymes implicated in their metabolism.
His academic activities at the Faculty of Pharmacy of the University of Barcelona have been mainly focused on subjects related to Medicinal Chemistry and Synthetic Organic Chemistry, being the coauthor of some textbooks on these topics. He has also dictated several postgraduate courses, both in the University of Barcelona and in other Universities of Spain and abroad.